Quantcast

How The Parts Add Up: PPH Headed For $69


Shutterstock photo

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel , we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. For the Pharmaceutical ETF (Symbol: PPH), we found that the implied analyst target price for the ETF based upon its underlying holdings is $68.51 per unit.

With PPH trading at a recent price near $62.39 per unit, that means that analysts see 9.81% upside for this ETF looking through to the average analyst targets of the underlying holdings. Three of PPH's underlying holdings with notable upside to their analyst target prices are Novo-Nordisk AS (Symbol: NVO), GW Pharmaceuticals plc (Symbol: GWPH), and AmerisourceBergen Corp. (Symbol: ABC). Although NVO has traded at a recent price of $48.51/share, the average analyst target is 24.51% higher at $60.40/share. Similarly, GWPH has 20.90% upside from the recent share price of $139.68 if the average analyst target price of $168.88/share is reached, and analysts on average are expecting ABC to reach a target price of $97.50/share, which is 15.93% above the recent price of $84.10. Below is a twelve month price history chart comparing the stock performance of NVO, GWPH, and ABC:

NVO, GWPH, and ABC Relative Performance Chart

Combined, NVO, GWPH, and ABC represent 11.35% of the Pharmaceutical ETF. Below is a summary table of the current analyst target prices discussed above:

Name Symbol Recent Price Avg. Analyst 12-Mo. Target % Upside to Target
Pharmaceutical ETF PPH $62.39 $68.51 9.81%
Novo-Nordisk AS NVO $48.51 $60.40 24.51%
GW Pharmaceuticals plc GWPH $139.68 $168.88 20.90%
AmerisourceBergen Corp. ABC $84.10 $97.50 15.93%

Are analysts justified in these targets, or overly optimistic about where these stocks will be trading 12 months from now? Do the analysts have a valid justification for their targets, or are they behind the curve on recent company and industry developments? A high price target relative to a stock's trading price can reflect optimism about the future, but can also be a precursor to target price downgrades if the targets were a relic of the past. These are questions that require further investor research.

10 ETFs With Most Upside To Analyst Targets ยป

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.





This article appears in: Investing , ETFs
Referenced Symbols: PPH , NVO , GWPH , ABC



More from BNK Invest

Subscribe






BNK Invest
Contributor:

BNK Invest

Market News, Investing










Research Brokers before you trade

Want to trade FX?